The trial has had a significant impact on the global response to the COVID-19 pandemic. By providing robust evidence on the efficacy of treatments like dexamethasone, the trial has directly influenced treatment guidelines and saved countless lives. Additionally, the trial's adaptive design serves as a model for future research in pandemic settings.